<DOC>
	<DOCNO>NCT00234988</DOCNO>
	<brief_summary>The purpose study determine safety weight loss sibutramine use overweight obese subject .</brief_summary>
	<brief_title>A Phase IV , Multi-Center , Open-Label Trial Sibutramine Combination With Hypocaloric Diet Obese Overweight Thai Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<criteria>Subject nutritional obesity BMI &gt; 30 kg/m Type 1 type 2 diabetes mellitus Inadequately control hypertension History Gilles de la Tourette 's Syndrome . Use MAOIs , SSRIs , amino acid , antimigraine drug , opioids Hypothyroidism hyperthyroidism . History : benign prostatic hyperplasia neurological disorder psychiatric illness severe renal hepatic impairment narrowangle glaucoma History cardiovascular disease cerebrovascular disease Persistent tachycardia rest Pulmonary hypertension Phaeochromocytoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Sibutramine</keyword>
	<keyword>Obesity</keyword>
</DOC>